Tenaya Therapeutics (TNYA) Cash from Investing Activities (2020 - 2026)

Tenaya Therapeutics' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$11000.0 for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 100.05% year-over-year to -$11000.0; the TTM figure through Mar 2026 stood at $33.8 million (up 20.94% YoY), while the FY2025 annual figure was $56.1 million, up 4858.71% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$11000.0, up from -$67000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $31.0 million in Q3 2022, with the low at -$30.1 million in Q3 2024.
• The 5-year median for Cash from Investing Activities is $14.1 million (2024), against an average of $11.2 million.
• The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities surged 1033.56% in 2022, then sank 349.73% in 2023.
• Tenaya Therapeutics' Cash from Investing Activities stood at $6.0 million in 2022, then tumbled by 349.73% to -$14.9 million in 2023, then jumped by 194.53% to $14.1 million in 2024, then tumbled by 100.48% to -$67000.0 in 2025, then surged by 83.58% to -$11000.0 in 2026.
• Business Quant data shows TNYA's Cash from Investing Activities at -$11000.0 in Q1 2026, -$67000.0 in Q4 2025, and $8.9 million in Q3 2025.